Cargando…

Utilisation of a thoracic oncology database to capture radiological and pathological images for evaluation of response to chemotherapy in patients with malignant pleural mesothelioma

OBJECTIVE: An area of need in cancer informatics is the ability to store images in a comprehensive database as part of translational cancer research. To meet this need, we have implemented a novel tandem database infrastructure that facilitates image storage and utilisation. BACKGROUND: We had previ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carey, George B, Kazantsev, Stephanie, Surati, Mosmi, Rolle, Cleo E, Kanteti, Archana, Sadiq, Ahad, Bahroos, Neil, Raumann, Brigitte, Madduri, Ravi, Dave, Paul, Starkey, Adam, Hensing, Thomas, Husain, Aliya N, Vokes, Everett E, Vigneswaran, Wickii, Armato, Samuel G, Kindler, Hedy L, Salgia, Ravi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2012
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488720/ https://www.ncbi.nlm.nih.gov/pubmed/23103606 http://dx.doi.org/10.1136/bmjopen-2012-001620

Ejemplares similares

Tumor volume is an independent predictor of survival in patients with malignant pleural mesothelioma
por: Kircheva, Diana Y, et al.
Publicado: (2015)

MET and PI3K/mTOR as a Potential Combinatorial Therapeutic Target in Malignant Pleural Mesothelioma
por: Kanteti, Rajani, et al.
Publicado: (2014)

Sphingosine Kinase 1 Is Required for Mesothelioma Cell Proliferation: Role of Histone Acetylation
por: Kalari, Satish, et al.
Publicado: (2012)

Role of protein kinase C β and vascular endothelial growth factor receptor in malignant pleural mesothelioma: Therapeutic implications and the usefulness of Caenorhabditis elegans model organism
por: Loganathan, Sivakumar, et al.
Publicado: (2011)

Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma
por: Lennon, Frances E., et al.
Publicado: (2016)

Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinoma
por: Rolle, Cleo E., et al.
Publicado: (2016)

O-6-methylguanine-deoxyribonucleic acid methyltransferase methylation enhances response to temozolomide treatment in esophageal cancer
por: Hasina, Rifat, et al.
Publicado: (2013)

EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesothelioma
por: Tan, Yi-Hung Carol, et al.
Publicado: (2019)

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
por: Surati, Mosmi, et al.
Publicado: (2011)

PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma
por: Kanteti, Rajani, et al.
Publicado: (2016)

Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database
por: Surati, Mosmi, et al.
Publicado: (2011)

Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer
por: Kanteti, Rajani, et al.
Publicado: (2014)

Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma
por: Kanteti, Rajani, et al.
Publicado: (2018)

Comment on “EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach”
por: Vigneswaran, Wickii T., et al.
Publicado: (2020)

Malignant Pleural Mesothelioma: Current Understanding of the Immune Microenvironment and Treatments of a Rare Disease
por: Tedesco, John, et al.
Publicado: (2022)

Systemic Treatments for Mesothelioma: Standard and Novel
por: Kindler, Hedy Lee
Publicado: (2008)

Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation
por: Vigneswaran, Janani, et al.
Publicado: (2016)

The EphB4 Receptor Tyrosine Kinase Promotes Lung Cancer Growth: A Potential Novel Therapeutic Target
por: Ferguson, Benjamin D., et al.
Publicado: (2013)

Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung Cancer
por: Ferguson, Benjamin D., et al.
Publicado: (2015)

MET/PKCß expression correlate with metastasis and inhibition is synergistic in lung cancer
por: Faoro, Leonardo, et al.
Publicado: (2009)

Exosomal miRNAs species in the blood of small cell and non-small cell lung cancer patients
por: Poroyko, Valeriy, et al.
Publicado: (2018)

Novel Therapeutic Targets and Immune Dysfunction in Malignant Pleural Mesothelioma
por: Lapidot, Moshe, et al.
Publicado: (2022)

FAK and paxillin, two potential targets in pancreatic cancer
por: Kanteti, Rajani, et al.
Publicado: (2016)

Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy
por: White, Michael G., et al.
Publicado: (2020)

Successful primary repair of late diagnosed spontaneous esophageal rupture: A case report
por: Kircheva, Diana Y., et al.
Publicado: (2017)

EphB4 as a therapeutic target in mesothelioma
por: Liu, Ren, et al.
Publicado: (2013)

Validation of Progression‐Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials
por: Wang, Xiaofei, et al.
Publicado: (2017)

Heuristic value-based framework for lung cancer decision-making
por: Mambetsariev, Isa, et al.
Publicado: (2018)

Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL
por: Tan, Yi-Hung Carol, et al.
Publicado: (2017)

Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma
por: Mitchell, Owen D., et al.
Publicado: (2023)

Video-Assisted Thoracoscopic Management of Post-Pneumonectomy Empyema
por: Podbielski, Francis J., et al.
Publicado: (1997)

Surgical treatment of pulmonary hypertension: Lung transplantation
por: Long, Jason, et al.
Publicado: (2011)

CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases
por: Tan, Yi-Hung Carol, et al.
Publicado: (2010)

A phase 2 randomized, double-blind, placebo-controlled study of tremelimumab for second and third line treatment in patients with unresectable pleural or peritoneal mesothelioma
por: Krug, Lee, et al.
Publicado: (2013)

The impact of marginal lung function on outcomes in the era of minimally invasive thoracic surgery
por: Nakahama, Hiroko, et al.
Publicado: (2021)

Molecular pathways and therapeutic targets in lung cancer
por: Shtivelman, Emma, et al.
Publicado: (2014)

Correction: CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases
por: Tan, Yi-Hung Carol, et al.
Publicado: (2011)

Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM)
por: Hassan, Raffit, et al.
Publicado: (2015)

Surgical Strategy of Complex Empyema Thoracis
por: Podbielski, Francis J., et al.
Publicado: (2000)

Thoracic Blastomycosis and Empyema
por: Wiesman, Irvin M., et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_m4fcr56f08ka6j14sos7dernej